These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11828603)
1. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)]. Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603 [TBL] [Abstract][Full Text] [Related]
2. [Antibacterial activity of biapenem against recent clinical isolates]. Hara T; Araake M; Watabe H Jpn J Antibiot; 2003 Apr; 56(2):138-41. PubMed ID: 12825414 [TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid]. Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628 [TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli]. Kinoshita S; Kumagai S Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282 [TBL] [Abstract][Full Text] [Related]
9. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents]. Igari J; Watanabe N; Uehara N; Inoue M; Yoshida H; Imafuku Y; Nishino T; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Matsuoka K; Oguri T; Ohba Y; Kumasaka K; Tokuda K; Kobayashi Y; Hongo T; Okada J; Sasaki T; Matsumoto N; Hirata Y; Nakasaki N; Ono J; Takata T; Kawaguchi R; Ohtaki Y; Kajimura K; Ishigo S; Hashimoto T; Aoki N; Okamoto E; Murakami E; Saeki H Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147 [TBL] [Abstract][Full Text] [Related]
10. [Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus]. Ito K; Hashimoto K; Ogata H Kekkaku; 2003 Sep; 78(9):587-90. PubMed ID: 14577345 [TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs]. Watanabe Y; Fujiue Y; Yano S; Shimizu S; Muroki K; Doi M; Kuwabara M Jpn J Antibiot; 2006 Apr; 59(2):65-71. PubMed ID: 16805317 [TBL] [Abstract][Full Text] [Related]
12. [Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa]. Arita K; Daido K; Ohashi N; Nakamura K; Takeshima Y; Kohara T Jpn J Antibiot; 1999 Jul; 52(7):491-6. PubMed ID: 10516928 [TBL] [Abstract][Full Text] [Related]
13. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001]. Abe T; Fukuoka T; Sato Y; Ito K; Sei M Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735 [TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activities of meropenem against clinically isolated strains in 1997]. Suzuki Y; Matsumoto Y; Nishinari C; Endo H; Ishihara R; Deguchi K Jpn J Antibiot; 1999 Dec; 52(12):695-720. PubMed ID: 10695025 [TBL] [Abstract][Full Text] [Related]
15. [In vitro antibacterial activities of carbapenems against clinical isolates]. Murase M Jpn J Antibiot; 1999 Nov; 52(11):667-79. PubMed ID: 10659443 [TBL] [Abstract][Full Text] [Related]
16. Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa. Shigemi A; Matsumoto K; Yaji K; Shimodozono Y; Takeda Y; Miyanohara H; Kawamura H; Orita M; Tokuda K; Nishi J; Yamada K Int J Antimicrob Agents; 2009 Dec; 34(6):589-91. PubMed ID: 19748231 [TBL] [Abstract][Full Text] [Related]
17. [The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum]. Fujiue Y; Kuwabara M; Muroki K; Shimizu S; Watanabe Y; Awaya Y; Kodomari Y Jpn J Antibiot; 1998 Jan; 51(1):26-36. PubMed ID: 9557274 [TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activities of meropenem against clinically isolated strains]. Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T Jpn J Antibiot; 1996 Feb; 49(2):175-93. PubMed ID: 8721078 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa. Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222 [TBL] [Abstract][Full Text] [Related]
20. [Comparative antibacterial activity of carbapenems against P. aeruginosa (2)]. Hikida M; Terashima S; Itahashi K; Sato Y; Okamoto R; Inoue M Jpn J Antibiot; 2003 Dec; 56(6):674-80. PubMed ID: 15007875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]